title: Polymorphic variants of genes involved in homocysteine metabolism in celiac disease.
abstract: Celiac disease (CD) is a polygenic chronic enteropathy conferring an increased risk for various nutrient deficiency states. Hyperhomocysteinemia is a frequent finding in CD and may be related to the development of venous thrombosis, cardiovascular disease, and stroke in untreated CD patients. Recently, a possible excess in the frequency of the MTHFR c.677C>T (rs1801133) gene variant in CD patients was reported. The purpose of this study was to determine if there exist differences in the distribution of polymorphic variants of genes involved in homocysteine/methyl group metabolism between CD patients and the general population. A set of 10 gene polymorphisms (MTHFR rs1801133, MTR rs1805087, MTHFD1 rs2236225, MTRR rs1801394, CBS 844ins68, BHMT1 rs7356530 and rs3733890, BHMT2 rs526264 and rs625879, and TCN2 rs1801198) was tested in 134 patients with CD and 160 matched healthy controls. The frequency of the MTR rs1805087 GG genotype in CD patients was lower than in controls (0.01 and 0.06, respectively), although statistical significance was not achieved (P = 0.06). For the other analyzed polymorphisms, there was no evidence of difference in both allelic and genotypic distribution between cases and controls. The exhaustive Multifactor Dimensionality Reduction analysis revealed no combination of interactive polymorphisms predicting the incidence of CD. In contrast to the well-documented clinical observations of increased risks of vascular disease in patients with longstanding untreated CD, in our group of patients no significant association with CD was found for all tested polymorphic variants of genes involved in homocysteine metabolism. These findings should be replicated in studies with a larger sample size.
authors.affiliation: Department of Pediatrics, Institute of Mother and Child, 17a Kasprzaka Street, 01-211 Warsaw, Poland. khozyasz@verco.com.pl
authors.forename: Kamil K
authors.initials: KK
authors.lastname: Hozyasz
authors.forename: Adrianna
authors.initials: A
authors.lastname: Mostowska
authors.forename: Anna
authors.initials: A
authors.lastname: Szaflarska-Poplawska
authors.forename: Margarita
authors.initials: M
authors.lastname: Lianeri
authors.forename: Pawel P
authors.initials: PP
authors.lastname: Jagodzinski
mesh_terms: D045103:5,10-Methylenetetrahydrofolate Reductase (FADH2) / Q000235:genetics; D013766:5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase / Q000235:genetics; D050940:Betaine-Homocysteine S-Methyltransferase / Q000235:genetics; D016022:Case-Control Studies; D002446:Celiac Disease / Q000201:enzymology* / Q000453:epidemiology* / Q000235:genetics; D003541:Cystathionine beta-Synthase / Q000235:genetics; D017931:DNA Primers / Q000235:genetics; D005287:Ferredoxin-NADP Reductase / Q000235:genetics; D005838:Genotype; D006710:Homocysteine / Q000378:metabolism*; D006801:Humans; D045102:Methylenetetrahydrofolate Dehydrogenase (NAD+) / Q000235:genetics; D011044:Poland / Q000453:epidemiology; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D014155:Transcobalamins / Q000235:genetics
chemical_list: C494551:BHMT2 protein, human; D017931:DNA Primers; D014155:Transcobalamins; D006710:Homocysteine; C111241:methionine synthase reductase; D005287:Ferredoxin-NADP Reductase; D045102:Methylenetetrahydrofolate Dehydrogenase (NAD+); D045103:5,10-Methylenetetrahydrofolate Reductase (FADH2); D013766:5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; C494548:BHMT protein, human; D050940:Betaine-Homocysteine S-Methyltransferase; D003541:Cystathionine beta-Synthase